{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:11:20Z","timestamp":1784182280928,"version":"3.55.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Traumatic hemorrhage is the predominant preventable cause of mortality in severe trauma cases. Timely and efficacious hemostatic resuscitation is crucial for the management of severe traumatic hemorrhages. This study aimed to evaluate the association between implementation of viscoelastic hemostatic assay (VHA)\/TEG-guided hemostatic resuscitation and clinical outcomes among transfused traumatic hemorrhage patients who survived at least 24 h after emergency department arrival in China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective, single-center before-after cohort study of trauma patients admitted to the emergency department of a tertiary trauma center from January 2012 to December 2021. Patients admitted from 2012 to 2016 were managed using a conventional coagulation assay (CCA)-guided strategy, whereas patients admitted from 2017 to 2021 were managed using a VHA\/TEG-guided strategy. Because the analysis required complete 24-h coagulation and transfusion-response data, the primary cohort was defined as transfused traumatic hemorrhage patients who survived at least 24 h after emergency department arrival. Propensity score matching was used to reduce baseline imbalance. The primary outcome was post-24-h in-hospital mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 154 patients who survived at least 24 h were included after propensity score matching, with 77 patients in each group. Post-24-h in-hospital death occurred in 21 of 77 patients in the CCA-guided group and 9 of 77 patients in the VHA-guided group. Kaplan\u2013Meier analysis showed improved post-24-h in-hospital survival in the VHA-guided group (log-rank\n                      <jats:italic>P<\/jats:italic>\n                      = 0.015). In multivariable Cox regression adjusting for age, ISS, APACHE II score, admission shock index, and baseline PT, VHA-guided resuscitation was associated with a lower hazard of post-24-h in-hospital death (adjusted HR 0.37, 95% CI 0.16\u20130.84,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.018). The VHA-guided group exhibited reduced plasma utilization and greater fibrinogen-directed replacement compared with the CCA-guided group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Among transfused traumatic hemorrhage patients who survived at least 24 h, VHA-guided hemostatic resuscitation was associated with improved post-24-h in-hospital survival, reduced plasma exposure, greater fibrinogen-directed replacement, and improved PT correction. This study cannot determine whether VHA-guided resuscitation improves survival during the initial 24 h, when early hemorrhagic mortality is highest. Because of the retrospective before-after design, survivorship bias, and residual confounding, these findings should be interpreted as hypothesis-generating.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1865755","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:40:39Z","timestamp":1784180439000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["VHA-guided resuscitation and post-24-hour survival in traumatic hemorrhage: a propensity- matched retrospective cohort study from China"],"prefix":"10.3389","volume":"13","author":[{"given":"Lincui","family":"Zhong","sequence":"first","affiliation":[{"name":"Intensive Care Unit, The 908th Hospital of Chinese PLA Logistic Support Force","place":["Nanchang, China"]},{"name":"Nanchang Key Laboratory of Thrombosis and Hemostasis","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Lin","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, The 908th Hospital of Chinese PLA Logistic Support Force","place":["Nanchang, China"]},{"name":"Nanchang Key Laboratory of Thrombosis and Hemostasis","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Song","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, The 908th Hospital of Chinese PLA Logistic Support Force","place":["Nanchang, China"]},{"name":"Nanchang Key Laboratory of Thrombosis and Hemostasis","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbo","family":"Zeng","sequence":"additional","affiliation":[{"name":"Nanchang Key Laboratory of Thrombosis and Hemostasis","place":["Nanchang, China"]},{"name":"Intensive Care Unit, Nanchang Hongdou Hospital of Traditional Chinese Medicine, Nanchang","place":["Jiangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longping","family":"He","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, The 908th Hospital of Chinese PLA Logistic Support Force","place":["Nanchang, China"]},{"name":"Nanchang Key Laboratory of Thrombosis and Hemostasis","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingchun","family":"Song","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, The 908th Hospital of Chinese PLA Logistic Support Force","place":["Nanchang, China"]},{"name":"Nanchang Key Laboratory of Thrombosis and Hemostasis","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019.","volume":"396","year":"2020","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","article-title":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the global burden of disease study 2016.","volume":"390","year":"2017","journal-title":"Lancet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00134-019-05560-x","article-title":"Why are bleeding trauma patients still dying?","volume":"45","author":"Brohi","year":"2019","journal-title":"Intensive Care Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.1007\/s00068-022-01998-9","article-title":"The conundrum of the definition of haemorrhagic shock: a pragmatic exploration based on a scoping review, experts\u2019 survey and a cohort analysis.","volume":"48","author":"James","year":"2022","journal-title":"Eur J Trauma Emerg Surg."},{"key":"B5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.47102\/annals-acadmedsg.2020381","article-title":"Trauma-induced coagulopathy: mechanisms and clinical management.","volume":"51","author":"Ho","year":"2022","journal-title":"Ann Acad Med Singap."},{"key":"B6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.12968\/hmed.2019.80.5.268","article-title":"What\u2019s new for trauma haemorrhage management?","volume":"80","author":"Vulliamy","year":"2019","journal-title":"Br J Hosp Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/SLA.0000000000001608","article-title":"Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays.","volume":"263","author":"Gonzalez","year":"2016","journal-title":"Ann Surg."},{"key":"B8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/TA.0b013e3180324124","article-title":"Damage control resuscitation: directly addressing the early coagulopathy of trauma.","volume":"62","author":"Holcomb","year":"2007","journal-title":"J Trauma."},{"key":"B9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13049-016-0327-z","article-title":"Pre-hospital transfusion of plasma in hemorrhaging trauma patients independently improves hemostatic competence and acidosis.","volume":"24","author":"Henriksen","year":"2016","journal-title":"Scand J Trauma Resusc Emerg Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"221.e","DOI":"10.1016\/j.wneu.2021.10.180","article-title":"Viscoelastic hemostatic assays and outcomes in traumatic brain injury: a systematic literature review.","volume":"159","author":"Shammassian","year":"2022","journal-title":"World Neurosurg."},{"key":"B11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1055\/s-0035-1564830","article-title":"Use of plasma for acquired coagulation factor deficiencies in critical care.","volume":"42","author":"Shah","year":"2016","journal-title":"Semin Thromb Hemost."},{"key":"B12","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1055\/s-0042-1756305","article-title":"Advances in the management of coagulopathy in trauma: the role of viscoelastic hemostatic assays across all phases of trauma care.","volume":"48","author":"Meizoso","year":"2022","journal-title":"Semin Thromb Hemost."},{"key":"B13","doi-asserted-by":"publisher","first-page":"E583","DOI":"10.1503\/cmaj.121986","article-title":"Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: a randomised feasibility trial.","volume":"185","author":"Nascimento","year":"2013","journal-title":"CMAJ."},{"key":"B14","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1007\/s00101-015-0093-8","article-title":"Haemoglobin-oriented and coagulation factor-based algorithm: effect on transfusion needs and standardized mortality rate in massively transfused trauma patients.","volume":"64","author":"Hilbert-Carius","year":"2015","journal-title":"Anaesthesist."},{"key":"B15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/ACO.0000000000000278","article-title":"Fixed ratio versus goal-directed therapy in trauma.","volume":"29","author":"Sch\u00f6chl","year":"2016","journal-title":"Curr Opin Anaesthesiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/1742-6723.13767","article-title":"Introduction of point-of-care ROTEM testing in the emergency department of an Australian level 1 trauma centre and its effect on blood product use.","volume":"33","author":"Bainbridge","year":"2021","journal-title":"Emerg Med Australas."},{"key":"B17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00134-020-06266-1","article-title":"Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial.","volume":"47","author":"Baksaas-Aasen","year":"2021","journal-title":"Intensive Care Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1016\/S2352-3026(17)30077-7","article-title":"Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-centre, parallel-group, open-label, randomised trial.","volume":"4","author":"Innerhofer","year":"2017","journal-title":"Lancet Haematol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13054-019-2347-3","article-title":"The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition.","volume":"23","author":"Spahn","year":"2019","journal-title":"Crit Care."},{"key":"B20","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1097\/00003246-198608000-00027","article-title":"APACHE II\u2013a severity of disease classification system.","volume":"14","author":"Le Gall","year":"1986","journal-title":"Crit Care Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"7219","DOI":"10.3390\/jcm11237219","article-title":"Early mortality risk in acute trauma patients: predictive value of injury severity score.","volume":"11","author":"Dai","year":"2022","journal-title":"J Clin Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13054-023-04327-7","article-title":"The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition.","volume":"27","author":"Rossaint","year":"2023","journal-title":"Crit Care."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1007\/s00134-022-06834-7","article-title":"Trauma-induced coagulopathy.","volume":"48","author":"Kleinveld","year":"2022","journal-title":"Intensive Care Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/MCC.0000000000000992","article-title":"Transfusion management in the trauma patient.","volume":"28","author":"Dilday","year":"2022","journal-title":"Curr Opin Crit Care"},{"key":"B25","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1097\/TA.0000000000003723","article-title":"Plasma-based assays distinguish hyperfibrinolysis and shutdown subgroups in trauma-induced coagulopathy.","volume":"93","author":"Lawson","year":"2022","journal-title":"J Trauma Acute Care Surg."},{"key":"B26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1182\/hematology.2020000090","article-title":"\u201cTEG talk\u201d: expanding clinical roles for thromboelastography and rotational thromboelastometry.","volume":"2020","author":"Selby","year":"2020","journal-title":"Hematology Am Soc Hematol Educ Program."},{"key":"B27","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/XCS.0000000000000078","article-title":"Role of fibrinogen in trauma-induced coagulopathy.","volume":"234","author":"Meizoso","year":"2022","journal-title":"J Am Coll Surg."},{"key":"B28","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1111\/trf.16488","article-title":"Evaluation of trauma-induced coagulopathy in the fibrinogen in the initial resuscitation of severe trauma trial.","volume":"61","author":"Peng","year":"2021","journal-title":"Transfusion."},{"key":"B29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/TA.0000000000003728","article-title":"Fibrinogen supplementation for the trauma patient: Should you choose fibrinogen concentrate over cryoprecipitate?","volume":"93","author":"Obaid","year":"2022","journal-title":"J Trauma Acute Care Surg."},{"key":"B30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13017-023-00497-5","article-title":"Emergency administration of fibrinogen concentrate for haemorrhage: systematic review and meta-analysis.","volume":"18","author":"Itagaki","year":"2023","journal-title":"World J Emerg Surg."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.injury.2020.05.044","article-title":"Targeted cryoprecipitate transfusion in severe traumatic haemorrhage.","volume":"51","author":"Ho","year":"2020","journal-title":"Injury."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/j.ajem.2020.06.075","article-title":"Prothrombin time ratio can predict mortality in severe pediatric trauma: study in a french trauma center level 1.","volume":"38","author":"Hochart","year":"2020","journal-title":"Am J Emerg Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1865755\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:40:41Z","timestamp":1784180441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1865755\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":32,"alternative-id":["10.3389\/fmed.2026.1865755"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1865755","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"article-number":"1865755"}}